Sharon Dayan - Nova Corporate Vice President of Human Resources
NVMI Stock | ILA 64,660 1,340 2.03% |
President
Ms. Sharon Dayan serves as Corporationrationrate Vice President of Human Resources at Nova Measuring Instruments Ltd since January 2018. Her work experience includes the following roles Senior Vice PresidentHuman Resources Business Partner at Teva Pharmaceutical Industries Limited, Global Head of Human Resources at Comverse and Employee at Amdocs. She holds a Bachelors degree in Social Sciences from The Academic College of TelAviv Yaffo and a Masters degree in Organizational Development from Tel Aviv University. Additionally, she holds a diploma in Group Dynamic from Tel Aviv University. since 2019.
Age | 50 |
Tenure | 5 years |
Phone | (972) 73 229 5760 |
Web | www.novami.com |
Nova Management Efficiency
The company has return on total asset (ROA) of 0.1055 % which means that it generated a profit of $0.1055 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2523 %, meaning that it generated $0.2523 on every $100 dollars invested by stockholders. Nova's management efficiency ratios could be used to measure how well Nova manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | PRESIDENT Age | ||
Marco Racanelli | Tower Semiconductor | 56 | |
Barry Cooper | Nice | 52 | |
Ran Kril | Elbit Systems | 52 | |
Itzhak Edrei | Tower Semiconductor | 58 | |
Eran Liron | Nice | 51 | |
David Temin | Elbit Systems | 67 | |
Yossi Netzer | Tower Semiconductor | 59 | |
Yehuda Vered | Elbit Systems | 65 | |
Edgar Maimon | Elbit Systems | 64 | |
Ilan Rabinovich | Tower Semiconductor | 61 | |
Shelly Gordon | Elbit Systems | 58 | |
Zmira ShternfeldLavie | Tower Semiconductor | 52 | |
Christopher Wooten | Nice | 57 | |
Jonathan Ariel | Elbit Systems | 62 | |
Ilan Pacholder | Elbit Systems | 64 | |
Yoram Shmuely | Elbit Systems | 62 | |
Oren Shirazi | Tower Semiconductor | 53 | |
Elad Aharonson | Elbit Systems | 45 | |
Yaron Hertz | Nice | N/A | |
Yehoshua Yehuda | Elbit Systems | 55 | |
Nati Somekh | Tower Semiconductor | 48 |
Management Performance
Return On Equity | 0.25 | |||
Return On Asset | 0.11 |
Nova Leadership Team
Elected by the shareholders, the Nova's board of directors comprises two types of representatives: Nova inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nova. The board's role is to monitor Nova's management team and ensure that shareholders' interests are well served. Nova's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nova's outside directors are responsible for providing unbiased perspectives on the board's policies.
Effi Aboody, Corporate VP and General Manager Dimensional Metrology Division | ||
Thomas Larson, VP Devel | ||
Avi Cohen, Independent Director | ||
Eitan Oppenhaim, President, Chief Executive Officer, Director | ||
Gabi Sharon, Corporate Vice President - Operations | ||
Udi Cohen, Corporate Vice President & General Manager Dimensional Metrology division | ||
Miron Kenneth, Independent Director | ||
Raanan Cohen, Independent Director | ||
Micha Brunstein, Independent Chairman of the Board | ||
Dafna Gruber, Independent & External Director | ||
Sharon Dayan, Corporate Vice President of Human Resources | ||
Dror David, Chief Financial Officer | ||
Zehava Simon, Independent & External Director | ||
Dov Farkash, Corporate Executive Vice President Strategic Development | ||
Adrian Wilson, President of US subsidiary & General Manager Material Metrology Division | ||
Gabriel Waisman, Chief Business Officer | ||
Zohar Gil, Corporate Vice President - Marketing and Business Development | ||
Shay Wolfling, Chief Technology Officer | ||
Eli Fruchter, Independent Director | ||
Ronnie Kenneth, Independent Director |
Nova Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nova a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.25 | |||
Return On Asset | 0.11 | |||
Profit Margin | 0.23 % | |||
Operating Margin | 0.27 % | |||
Current Valuation | 8.39 B | |||
Shares Outstanding | 28.59 M | |||
Shares Owned By Insiders | 0.69 % | |||
Shares Owned By Institutions | 78.21 % | |||
Price To Book | 4.43 X | |||
Price To Sales | 15.58 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Nova Stock
When determining whether Nova offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nova's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nova Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nova Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nova. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Nova Stock refer to our How to Trade Nova Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.